The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]

Onco Targets Ther. 2017 May 4:10:2425. doi: 10.2147/OTT.S140498. eCollection 2017.

Abstract

[This retracts the article on p. 1735 in vol. 10, PMID: 28356761.].

Publication types

  • Retraction of Publication